Sean Gaskell joins Alvotech with over 15 years of industry experience, bringing deep expertise in biologic manufacturing across a variety of platforms, pharmaceutical and chemical operations, technical operations strategy, QA compliance and research chemistry. Most recently, Sean was VP of Manufacturing Operations and Site Head at AveXis and played an integral role in the transformational change of its core facility producing AAV9-based gene therapies, enabling the company to become a commercial supplier of live-saving medicines for patients with rare diseases.
Prior to AveXis, Sean held various roles of increasing responsibility at Novartis. Most recently he was Site Head in charge of Drug Substance Bioproduction for Novartis’ Basel, Switzerland facility. He again drove the transformation of the site from clinical pilot plant to commercial manufacturing facility for both innovative and biosimilar biologics, accelerating the launch of three commercial products under his leadership. Other notable roles include strategic assistant to Novartis’ Global Head of Technical Operations, charged with developing, implementing and monitoring the company’s long-term technical operations strategy across more than 50 sites worldwide, and Process Unit Head of Chemical Operations.
Starting out his career as a research chemist, Sean holds a Bachelor of Science with first class honors in chemistry and a PhD in organic chemistry from Loughborough University, UK.